GMGita Mishra

Gita Mishra

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Gita Mishra has a total of 9 co-authors. Here are the top co-authors by number of shared publications:

  • Hemeshwer Kumar Chandra

    Toxicology and Pharmacology Laboratory, Department of Zoology, Guru Ghasidas University, Bilaspur, 495009 (CG), India

    3 shared publications
  • Nisha Sahu

    Toxicology and Pharmacology Laboratory, Department of Zoology, Guru Ghasidas University, Bilaspur, 495009 (CG), India

    3 shared publications
  • Satendra Kumar Nirala

    Laboratory of Natural Products, Department of Rural Technology and Social Development, Guru Ghasidas University, Bilaspur, 495009 (CG), India

    3 shared publications
  • Monika Bhadauria

    Department of Zoology, Toxicology and Pharmacology Laboratory, Guru Ghasidas University, Bilaspur, Chhattisgarh, India

    2 shared publications
  • Bipasha Biswas

    Guru Ghasidas Vishwavidyalaya

    1 shared publication
  • Lvks Bhaskar

    Department of Zoology, Guru Ghasidas Vishwavidyalaya

    1 shared publication

Latest Publications

  • Keratin-based electrospun nanofibers for drug delivery and tissue engineering applications

    by Bipasha Biswas, Gita Mishra

    Keratin-based electrospun nanofibers have gained increasing attention as promising biomaterials for drug delivery and tissue engineering due to their intrinsic biocompatibility, bioactivity, and controlled biodegradability. Keratin is rich in functional groups and natural cell-recognition motifs, enabling favorable cell–material interactions, including enhanced adhesion, proliferation, and differentiation. When processed into nanofibrous scaffolds via electrospinning, keratin can closely replicate the nanoscale architecture of the native extracellular matrix, offering high surface area and interconnected porosity that support therapeutic loading and tissue regeneration. This review critically summarizes recent progress in the fabrication of keratin-based electrospun nanofibers, with particular emphasis on electrospinning parameters, keratin–polymer blending strategies, and surface modification approaches used to tailor fiber morphology, mechanical properties, and degradation behavior. Methods for incorporating small-molecule drugs, proteins, growth factors, and nanoparticles are discussed, highlighting their influence on encapsulation efficiency, release profiles, and biological performance. Key biomedical applications are reviewed, including wound healing, skin and soft-tissue repair, bone and cartilage regeneration, and localized cancer therapy, where keratin nanofibers have demonstrated improved healing outcomes, reduced infection, and enhanced tissue integration compared with conventional biomaterial systems. Current challenges related to keratin source variability, limited mechanical strength for load-bearing applications, scalability, and regulatory translation are analyzed. Finally, future perspectives are outlined, focusing on hybrid and stimuli-responsive keratin-based nanofibers and sustainable processing strategies, underscoring their potential as clinically relevant platforms for advanced biomaterials applications.

  • Open Access

    Interleukin-10 gene promoter variants and susceptibility to diabetic nephropathy; a meta-analysis

    by Gita Mishra, Sudeep Gautam, Thavanati Parvathi Kumara Reddy, Bhaskar Vks Lakkakula

    Introduction: Diabetic nephropathy (DN) is a leading cause of chronic kidney disease (CKD) in diabetes patients. There is ample evidence that the inflammatory pathways are central to both diabetes and DN. Several studies that examined the link between the interleukin-10 (IL10) polymorphisms and DN risk yielded conflicting results. Objectives: The purpose of this meta-analysis is to evaluate the associations between IL10 promoter polymorphisms and DN risk. Methods: A bibliographic search was carried out on PubMed, Google scholar and Web of Science from the beginning until July 30, 2020. Association between IL10 promoter variants (-1082 A>G, -819 C>T and -592 C>A) and DN risk were assessed by considering diabetes without nephropathy (DWN) as well as healthy controls. Data were retrieved and the pooled odds ratio (OR) with 95% confidence interval (CI) was calculated. Results: For the IL10 -1082 A> G analysis, a total of 4 studies with DWN controls (682 cases and 529 controls) and 5 studies with healthy controls (1025 cases and 1625 controls) were considered. For the IL10 -819 C> T analysis, a total of three studies with DWN controls (9619 cases and 445 controls) and 5 studies with healthy controls (1005 cases and 1537 controls) were considered. For the IL10 -592 C> T analysis, a total of 5 studies with DWN controls (819 cases and 645 controls) and 5 studies with healthy controls (1005 cases and 1537 controls) were considered. In addition, there was no evidence of publication bias for IL10 promoter variants. No substantial association was observed between IL10 promoter variants and DN risk. Conclusion: Our study signifies that polymorphisms of IL10 -1082 A>G, -819 C>T and -592 C>A are not linked with DN risk.

  • Open Access

    Naringenin mitigates antituberculosis drugs induced hepatic and renal injury in rats

    by Nisha Sahu, Gita Mishra, Hemeshwer Kumar Chandra, Satendra Kumar Nirala, Monika Bhadauria


  • Propolis modulates cellular biochemistry, antioxidants, cytokine profile, histological and ultra-morphological status against antituberculosis drugs induced hepatic injury

    by Monika Bhadauria, Nisha Sahu, Gita Mishra, Hemeshwer Kumar Chandra, Satendra Kumar Nirala

    Objective: To evaluate hepatic injury induced by antituberculosis drugs (ATDs) when administered orally for 2, 4, 6 and 8 weeks and the therapeutic potential of propolis (bee hive product) against ATDs induced hepatic injury. Methods: The ATDs were administered for 8 weeks as well as propolis extract at three different doses (100, 200, 400 mg/kg) conjointly for 8 weeks in rats. Silymarin (50 mg/kg) was given as positive control. Animals were euthanized after 8 weeks; blood and liver samples were collected to perform various biochemicals, serological and histopathological and ultramorphological studies. Results: Significant increase (P < 0.05) in aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, triglyceride and cholesterol along with reduction in glucose and albumin level were noted after ATDs induced hepatic injury. Significant increase (P < 0.05) in lipid peroxidation, triglyceride, cholesterol and CYP2E1 activity; decline in reduced glutathione, catalase, superoxide dismutase, glutathione reductase, glutathione peroxidase, glucose-6-phosphatase dehydrogenase activity were observed after ATDs intoxication. Due to presence of a wide range of flavonoids and polyphenols in propolis extract, its administration reduced hepatic injury and maintained biochemical indices towards control. Histopathological and electron microscopic observations indicated hepatoprotective potential of propolis at cellular level whereas, TNF-α, IL-6 and IGF-1 confirmed therapeutic potential of propolis at molecular level. Conclusions: It can be concluded that propolis possess hepatoprotective potential against ATDs induced hepatic injury that may prove itself as a clinically useful natural product in management of drug induced liver injury.


  • Ameliorative effect of Pergularia daemia (Forssk.) Chiov. leaves extract against anti-tuberculosis drugs induced liver injury in rats

    by Monika Bhadauria, Gita Mishra, Hemeshwer Kumar Chandra, Nisha Sahu, Satendra Kumar Nirala

    Objective: To evaluate therapeutic potential of hydroethanolic extract of Pergularia daemia (P. daemia) against anti-tuberculosis drugs (ATDs) induced liver injury. Methods: Wistar albino rats were divided into seven groups of six animal in each. The ATDs and P. daemia extract (100, 200 and 400 mg/kg, p.o.) were conjointly administered for 8 weeks and various biochemical, histoarchitectural, ultrastructural studies were performed. Results: Administration of ATDs significantly increased aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, triglycerides, cholesterol, bilirubin and decreased glucose and albumin level. Increased lipid peroxidation and reduction in glutathione, superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase and glucose-6-phosphate dehydrogenase were found after ATDs exposure. Administration of P. daemia extract maintained serum biochemical indices as well as antioxidant status similar to control and diminished oxidative stress in dose dependent manner. Histological and ultra-structural observations substantiated biochemical findings. Conclusions: P. daemia has therapeutic potential against ATDs induced liver injury and may be of clinical significance after extensive studies.